Valuation: Camurus AB

Market Cap 36.93B 3.81B 3.34B 3.09B 2.85B 5.37B 367B 5.43B 14.45B 180B 14.3B 13.99B 621B P/E 2026 *
38.9x
P/E 2027 * 25.1x
Enterprise Value 32.36B 3.34B 2.93B 2.71B 2.5B 4.71B 322B 4.76B 12.66B 158B 12.53B 12.26B 544B EV / Sales 2026 *
11.4x
EV / Sales 2027 * 8.21x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+0.24%
1 week+17.85%
Current month+9.73%
1 month+19.56%
3 months+11.40%
6 months-6.83%
Current year+0.73%
1 week 609
Extreme 609
645
1 month 508.5
Extreme 508.5
645
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 279.2
Extreme 279.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 31/12/2002
Director of Finance/CFO 57 30/06/2025
Chief Tech/Sci/R&D Officer 58 31/12/2024
Director TitleAgeSince
Director/Board Member 63 31/12/2001
Chairman 77 31/12/2014
Director/Board Member 61 06/05/2020
Date Insider Type Main position Quantity % Market Cap.
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
27/02/26 Sell

Chief Executive Officer

9,950 0.0166%
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%+17.85%-12.48%+103.04% 3.8B
+2.49%+1.98%+54.22%+154.40% 1,023B
+0.72%-1.28%+52.48%+47.25% 599B
+1.07%+4.62%+38.54%+78.17% 448B
+0.63%+2.08%+30.59%+21.56% 326B
+1.98%+2.55%+37.13%+37.55% 278B
+0.90%+1.04%+22.09%+15.99% 258B
-1.20%+1.36%-21.14%-41.57% 222B
+0.57%+3.09%+23.78%+55.97% 197B
-2.20%+0.18%+20.32%+61.56% 165B
Average +0.07%+2.50%+24.55%+53.39% 351.89B
Weighted average by Cap. -0.19%+1.22%+37.92%+72.51%

Financials

2026 *2027 *
Net sales 2.85B 294M 257M 239M 220M 414M 28.28B 419M 1.11B 13.86B 1.1B 1.08B 47.86B 3.79B 391M 343M 318M 292M 551M 37.66B 558M 1.48B 18.46B 1.47B 1.44B 63.73B
Net income 968M 99.89M 87.55M 81.12M 74.67M 141M 9.62B 143M 379M 4.71B 375M 367M 16.28B 1.45B 150M 131M 122M 112M 211M 14.44B 214M 569M 7.08B 563M 551M 24.43B
Net Debt -4.56B -471M -413M -382M -352M -664M -45.34B -672M -1.79B -22.22B -1.77B -1.73B -76.73B -5.81B -599M -525M -487M -448M -844M -57.7B -855M -2.27B -28.28B -2.25B -2.2B -97.64B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
21/07/26 SEK 620.50 +0.24% 106,406
20/07/26 SEK 619.00 -1.51% 47,024
17/07/26 SEK 628.50 -1.64% 67,377
16/07/26 SEK 639.00 +3.90% 109,880
15/07/26 SEK 615.00 +16.81% 380,833
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
620.50SEK
Average target price
776.75SEK
Spread / Average Target
+25.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock